Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line

OBJECTIVES: The objectives of this study were to 1) describe and compare treatment persistence with first- and second-line subcutaneous tumor necrosis factor-alpha inhibitors (SC-TNFis) in patients with ankylosing spondylitis (AS), psoriatic arthritis (PsA), or rheumatoid arthritis (RA) (collectivel...

Full description

Saved in:
Bibliographic Details
Published in:Patient Prefer Adherence
Main Authors: Svedbom, Axel, Dalén, Johan, Black, Christopher M, Kachroo, Sumesh
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2017
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5248937/
https://ncbi.nlm.nih.gov/pubmed/28144130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S119808
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items